Today: 14 March 2026
Subscribe
Browse Category

Stock Market 11 December 2025

Crypto Stocks Today: Coinbase, Marathon, Riot Slide as Bitcoin Tests $90K After Fed Cut – US Market Wrap (December 11, 2025)

Crypto Stocks Today: Coinbase, Marathon, Riot Slide as Bitcoin Tests $90K After Fed Cut – US Market Wrap (December 11, 2025)

Bitcoin slipped below $90,000 before recovering, down 2–3% Thursday, as US-listed crypto stocks fell sharply following a hawkish Federal Reserve rate cut and a sell-off in Oracle. Coinbase dropped about 4% to $264 after announcing USDC rewards will soon be limited to paying subscribers. The Dow hit a record, but the Nasdaq fell nearly 1%. Miners and crypto ETFs also declined 3–6%.
11 December 2025
········
New Gold Inc (NGD) Stock: 201% Rally, $7 Billion Coeur Mining Buyout and December 2025 Analyst Outlook

New Gold Inc (NGD) Stock: 201% Rally, $7 Billion Coeur Mining Buyout and December 2025 Analyst Outlook

New Gold Inc. shares surged 201% over the past year, trading near C$11.37 on the TSX and US$7.80 on NYSE American as of December 11, 2025. The company posted record Q3 free cash flow of US$205 million and agreed to a $7 billion all-stock takeover by Coeur Mining. New Gold’s market cap stands at roughly US$6.2 billion, with analysts issuing unusually bullish “Buy” ratings.
11 December 2025
·····
Polestar Automotive (PSNY) Stock Plunges After Reverse Split – Latest News, Analyst Forecasts and 2025–2026 Outlook

Polestar Automotive (PSNY) Stock Plunges After Reverse Split – Latest News, Analyst Forecasts and 2025–2026 Outlook

Polestar shares plunged over 20% Wednesday and slid further Thursday, trading near $12.45 after a 1-for-30 reverse stock split and a Nasdaq compliance warning. The stock hit a new 52-week low despite reporting nearly 50% revenue growth for 2025 so far. Technical analysts now rate PSNY a “Strong Sell,” projecting up to 46% more downside in the next three months.
11 December 2025
·
Wave Life Sciences (WVE) Stock on December 11, 2025: Obesity Breakthrough, 180% Rally, $350M Offering and Fresh Analyst Targets

Wave Life Sciences (WVE) Stock on December 11, 2025: Obesity Breakthrough, 180% Rally, $350M Offering and Fresh Analyst Targets

Wave Life Sciences shares surged over 180% in a week after Phase 1 data showed its obesity drug WVE-007 reduced visceral fat by up to 10% and increased lean mass. The stock hit a five-year high near $22 before retreating to $17.06 following a $350 million equity offering and insider selling. Analyst price targets jumped, but Wave remains unprofitable with high valuation risk.
11 December 2025
···
First Majestic Silver (AG) Blasts to a 52‑Week High as Silver Hits Records – Can the Run Last?

First Majestic Silver (AG) Blasts to a 52‑Week High as Silver Hits Records – Can the Run Last?

First Majestic Silver shares hit a 52-week high of $16.30 on December 11, trading near $16.50 intraday, after silver prices reached all-time highs. The stock is up about 185–190% year-to-date, lifting market cap to $7.5–8.0 billion. Q3 2025 saw record silver production of 3.9 million ounces and EBITDA of $128.6 million. Net earnings reached $43 million, reversing a loss from last year.
11 December 2025
···
Cisco (CSCO) Stock Outlook After November 21, 2025: AI Joint Ventures, Record Highs and Analyst Targets

Cisco (CSCO) Stock Outlook After November 21, 2025: AI Joint Ventures, Record Highs and Analyst Targets

Cisco shares hit a record closing high of $80.25 on December 10, surpassing their dot-com era peak. The stock is up about 36% in 2025, fueled by strong Q1 results, $1.3 billion in AI infrastructure orders, and new Saudi and Iraq network deals. Wall Street price targets now cluster in the mid-$80s, with some as high as $90.
11 December 2025
···
Caterpillar (CAT) Stock Near Record Highs on AI Data Center Boom: Latest News, Analyst Targets and 2026–2030 Forecasts

Caterpillar (CAT) Stock Near Record Highs on AI Data Center Boom: Latest News, Analyst Targets and 2026–2030 Forecasts

Caterpillar shares closed at $616.96 on December 11, up over 12% since November 21 and more than 60% in the past year. Q3 2025 sales reached $17.6 billion, led by a 31% jump in power generation revenue for data centers. Operating margin fell to about 17–18% due to tariffs and higher manufacturing costs. The stock trades near record highs, with a forward dividend yield under 1%.
11 December 2025
·
Visa Inc. (V) Stock Forecast 2026: BofA Upgrade, Stablecoin Push and What’s Changed Since November 21, 2025

Visa Inc. (V) Stock Forecast 2026: BofA Upgrade, Stablecoin Push and What’s Changed Since November 21, 2025

Visa shares climbed to $338.10 on December 11, up 3–4% on the day, but remain about 10% below their June 2025 record high. The move follows a Bank of America upgrade, analyst reports, and strong fiscal Q4 results, with EPS at $2.98 and net revenue at $10.7 billion, both above estimates. Trading volume and insider share activity have increased since November 21. Visa’s market cap stands near $593 billion.
11 December 2025
··
UK Stock Market Today (11 December 2025): FTSE 100 Closes Higher Near Record Highs After Fed Cut as BoE Bets Build

UK Stock Market Today (11 December 2025): FTSE 100 Closes Higher Near Record Highs After Fed Cut as BoE Bets Build

The FTSE 100 closed at 9,711.47 on Thursday, up 0.6%, staying just below its record high set in November. The session followed a third straight US Federal Reserve rate cut and rising bets the Bank of England will ease policy next week. The FTSE 250 was flat, while AIM All-Share edged higher. Oracle shares fell 11% after weak results, fueling renewed concern over AI-linked tech valuations.
11 December 2025
····
US Stock Market Today, December 11, 2025: Dow Climbs While Oracle-Led AI Sell-Off Hits Nasdaq After Fed Rate Cut

US Stock Market Today, December 11, 2025: Dow Climbs While Oracle-Led AI Sell-Off Hits Nasdaq After Fed Rate Cut

The Dow rose 0.6–0.9% by late morning Thursday, while the S&P 500 slipped 0.2–0.5% and the Nasdaq fell nearly 1% as investors sold off AI-linked stocks following Oracle’s 14% plunge. The split comes a day after the Fed cut rates for the third time in 2025 and the S&P 500 closed just below its record high.
11 December 2025
····
EU Stock Market Today, 11 December 2025: Cyclicals Rally While Tech Stumbles After Fed Rate Cut and SNB Hold

EU Stock Market Today, 11 December 2025: Cyclicals Rally While Tech Stumbles After Fed Rate Cut and SNB Hold

European stocks closed higher on December 11, with the STOXX Europe 600 up 0.66% and the Euro Stoxx 50 gaining 1.0%, as investors favored financials and cyclicals after the Fed’s rate cut. Germany’s DAX and Spain’s IBEX 35 hit new highs. Technology shares lagged, with SAP dropping up to 3% after Oracle’s weak outlook revived concerns over AI sector profits.
11 December 2025
····
Canada Stock Market Today: TSX Near Record High as Mining Stocks Climb, Tech and Energy Lag – December 11, 2025

Canada Stock Market Today: TSX Near Record High as Mining Stocks Climb, Tech and Energy Lag – December 11, 2025

The S&P/TSX Composite Index hit a new intraday high near 31,546 in Toronto Thursday, up 0.3%, after closing at a record 31,490.85 on Wednesday. Gains in gold and base-metal miners offset losses in technology and energy shares. The Bank of Canada held its policy rate at 2.25% on Wednesday, following the U.S. Federal Reserve’s rate decision. Year-to-date, the TSX is up about 27%.
11 December 2025
···
UnitedHealth Group (UNH) Stock Outlook After the November 21 Rebound: Can the Healthcare Giant Regain Its Swagger in 2026?

UnitedHealth Group (UNH) Stock Outlook After the November 21 Rebound: Can the Healthcare Giant Regain Its Swagger in 2026?

UnitedHealth shares climbed to $332–334 intraday on December 11, up from $319.97 on November 21, but remain down about 35% over the past year. The stock trades at a trailing P/E of 14.9×, below sector average, but a forward P/E of 19×, slightly above peers. Dividend yield stands at 2.8%, with the next payout set for December 16. DOJ probe and Medicare Advantage reset continue to weigh on outlook.
11 December 2025
·
Immunovant (IMVT) Stock Jumps After $550 Million Share Offering as Graves’ Disease Launch Comes Into Focus

Immunovant (IMVT) Stock Jumps After $550 Million Share Offering as Graves’ Disease Launch Comes Into Focus

Immunovant shares rose 9% to $25.75 Thursday after the company announced a $550 million common stock offering to fund development and possible launch of its lead drug, IMVT‑1402, for Graves’ disease. The offering priced at $21 per share, an 11% discount, and is expected to close December 12. Roivant Sciences will participate. Immunovant’s market value reached about $4 billion.
11 December 2025
····
AbbVie Stock (ABBV): HSBC Upgrade, Dividend Hike and New FDA Win Reshape the 2025 Outlook

AbbVie Stock (ABBV): HSBC Upgrade, Dividend Hike and New FDA Win Reshape the 2025 Outlook

AbbVie shares rebounded 2.98% to $236.28 on Nov. 21, 2025, with trading volume spiking to 7.9 million after three down days. Year-to-date, the stock is up about 22–26%, outpacing the S&P 500, but remains 7–9% below its October high. Forward P/E estimates range from 16x to 22x. Investors weigh strong Skyrizi and Rinvoq sales against Humira declines and regulatory risk.
11 December 2025
···
Coeur Mining (CDE) Stock on December 11, 2025: Palmarejo Breakthroughs, $7B New Gold Deal and What Comes Next

Coeur Mining (CDE) Stock on December 11, 2025: Palmarejo Breakthroughs, $7B New Gold Deal and What Comes Next

Coeur Mining shares traded around $16.84 on December 11, up 5% intraday, with volume over 6 million. The company announced a $7 billion all-stock deal to acquire New Gold Inc. and posted record Q3 revenue of $555 million and net income of $267 million. CDE’s market value has surged to about $10 billion after a rally from a 52-week low of $4.58 to a high near $23.61.
11 December 2025
···
Snowflake (SNOW) Stock Outlook After November 21, 2025: AI Deals, Legal Risks and Price Targets to 2030

Snowflake (SNOW) Stock Outlook After November 21, 2025: AI Deals, Legal Risks and Price Targets to 2030

Snowflake shares have fallen to around $218, down 7% since November 21 and 22% below their November 3 high. The stock dropped sharply after Q3 FY26 earnings on December 3, when strong growth was offset by weaker margin guidance. Shares remain over 50% higher year-to-date. Wall Street analysts have since raised price targets despite the recent slide.
11 December 2025
··
Linde Stock (LIN) Outlook for 2026: What 52‑Week Lows, Insider Buying and New Debt Deals Signal for Investors

Linde Stock (LIN) Outlook for 2026: What 52‑Week Lows, Insider Buying and New Debt Deals Signal for Investors

Linde shares hit a 52-week low of $387.78 in late November 2025, trading at $398.9 on December 11, below key moving averages. CEO insider buying and new analyst calls followed, along with multiple debt and credit moves. Q3 adjusted EPS rose to $4.21 on $8.6 billion revenue, but weak European volumes and cautious Q4 guidance pressured the stock. Market cap stands at about $186 billion.
11 December 2025
·
1 … 965 966 967 968 969 … 1,350

Stock Market Today

  • Trinity Capital (TRIN) Faces Valuation Scrutiny Amid Share Price Decline
    March 14, 2026, 12:50 PM EDT. Trinity Capital (TRIN) shares fell 1.8% recently, with negative returns over one, three months, raising questions about its valuation. Trading at $14.42 with a price-to-earnings (P/E) ratio of 8.8x, the stock appears undervalued against its fair P/E estimate of 12x and the broader U.S. Capital Markets industry average of 22x. Despite short-term share price weakness, TRIN posted a 7.9% one-year total shareholder return and a 112.4% five-year return, reflecting long-term gains. Investors weigh these factors alongside the firm's exposure to private credit risks and potential portfolio performance challenges. The mixed P/E comparisons suggest market uncertainty about growth prospects and earnings stability in Trinity's business development and private lending operations.
Go toTop